International
Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Estonia
Hungary
Latvia
Lithuania
Kosovo
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland (German)
Switzerland (French)
Business Development
Mediji
Mednarodni dogodki
Zaposlitev
Stik z nami
Izdelki
Zdravila na recept
Ostali izdelki
Partnerji in blagovne znamke
Mnenje
O nas
Vizija/Poslanstvo
Naše vrednote
Naša strategija
Vodstvo
Družbena odgovornost
Kje smo prisotni
Business Development
Mediji
Mednarodni dogodki
Zaposlitev
Stik z nami
International
Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Estonia
Hungary
Latvia
Lithuania
Kosovo
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland (German)
Switzerland (French)
Mediji
OBJAVE ZA JAVNOST
1
2
3
4
Naprej
15.04.2026
Sugemalimab Receives I, A Recommendation in ESMO Guideline for Consolidation Therapy in Patients with Stage Ⅲ NSCLC
Preberi več
26.02.2026
BioGaia AB extends long-standing distribution partnership with Ewopharma
Preberi več
16.12.2025
Sugemalimab Achieves New Regulatory Milestone: European Commission Approves Stage Ⅲ NSCLC Indication
Preberi več
31.07.2024
European Commission Approves Sugemalimab
Preberi več
03.06.2024
Allergycare AG becomes part of Ewopharma Group
Preberi več
1
2
3
4
Naprej
![[Translate to Slovenia:]](/fileadmin/user_upload/Ewopharma_CStone_Sugemalimab_01.png "[Translate to Slovenia:]")
